Cargando…
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy
Malignant germ cell tumours are a group of rare cancers whose incidence peaks in late adolescence and early adulthood. Dysgerminomas of the ovary and seminomas of the testis are analogous diseases, but seminomas have a 10-fold higher incidence. The two tumours are morphologically identical and are o...
Autores principales: | Wood, Georgina E., Bunting, Christopher P., Veli, Mesel, Arora, Rupali, Berney, Daniel M., Alifrangis, Constantine, MacDonald, Nicola D., Miller, Rowan E., Shamash, Jonathan, Stoneham, Sara, Lockley, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634240/ https://www.ncbi.nlm.nih.gov/pubmed/37954076 http://dx.doi.org/10.3389/fonc.2023.1271647 |
Ejemplares similares
-
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
por: Newton, C., et al.
Publicado: (2019) -
Management of stage II seminoma: a contemporary UK perspective
por: Alifrangis, Constantine, et al.
Publicado: (2022) -
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
por: Shamash, Jonathan, et al.
Publicado: (2020) -
OVARIAN DYSGERMINOMA IN TWO SISTERS
por: Aldhafery, Bander F.
Publicado: (2008) -
Chemotherapy of metastatic seminoma.
por: Schuette, J., et al.
Publicado: (1985)